InvestorsHub Logo
Followers 4
Posts 309
Boards Moderated 0
Alias Born 07/09/2018

Re: mick post# 854

Thursday, 03/10/2022 10:24:43 AM

Thursday, March 10, 2022 10:24:43 AM

Post# of 1032
ECOR responds to the strategic failure of its headache device by appointing 2 new directors to Board. They bring entertainment, fashion & media backgrounds to this flailing medical device company. They have no medical device or FDA-regulated products experience. ECOR is apparently doubling down on its prior fundamental mistake of using a once promising medical technology in a junk application by trying to go direct to the consumer. At best, this could be a bridge to somewhere else. But to where? And do they have the capital for it? CEO is mute to shareholders. Annual meeting will be interesting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ECOR News